THE USE OF THIN-LAYER CHROMATOGRAPHY IN EXPERIMENTAL XENOBIOLOGYMIGDALOF BH.1981; J. LIQ. CHROMATOGR.; ISSN 0148-3919; USA; DA. 1981; VOL. 4; NO 6; PP. 931-953; BIBL. 6 REF.Article

DRUG METABOLISMMIGDALOF BH.1978; ANNU. REP. MEDICIN. CHEM.; USA; DA. 1978; VOL. 13; PP. 196-205; BIBL. 3 P.Article

METHODS FOR OBTAINING DRUG TIME COURSE DATA FROM INDIVIDUAL SMALL LABORATORY ANIMALS: SERIAL MICROBLOOD SAMPLING AND ASSAY.MIGDALOF BH.1976; DRUG METABOL. REV.; U.S.A.; DA. 1976; VOL. 5; NO 2; PP. 295-310; BIBL. 2 P.Article

BIOTRANSFORMATION OF THE DISULFIDE OF CAPTOPRIL IN SUBCELLULAR FRACTIONS OF RAT TISSUESSHIH JUNG LAN; WEINSTEIN SH; MIGDALOF BH et al.1982; DRUG. METAB. DISPOS.; ISSN 0090-9556; USA; DA. 1982; VOL. 10; NO 4; PP. 306-311; BIBL. 32 REF.Article

THE COMPARATIVE METABOLISM AND DISPOSITION OF PENFLURIDOL-³H IN THE RAT, RABBIT, DOG, AND MANGRINDEL JM; MIGDALOF BH; CRESSMAN WA et al.1979; DRUG METABOL. DISPOSIT.; USA; DA. 1979; VOL. 7; NO 5; PP. 325-329; BIBL. 13 REF.Article

CAPTOPRIL KINETICSDUCHIN KL; SINGHVI SM; WILLARD DA et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 31; NO 4; PP. 452-458; BIBL. 14 REF.Article

CHARACTERIZATION OF A NEW URINARY METABOLITE OF PENFLURIDOL IN THE RAT, RABBIT, DOG AND MANGRINDEL JM; MIGDALOF BH; HILLS JF et al.1979; DRUG METABOL. DISPOSIT.; USA; DA. 1979; VOL. 7; NO 6; PP. 448; BIBL. 3 REF.Article

ABSORPTION AND EXCRETION OF TOLMETIN IN ARTHRITIC PATIENTSGRINDEL JM; MIGDALOF BH; PLOSTNIEKS J et al.1979; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1979; VOL. 26; NO 1; PP. 122-128; BIBL. 12 REF.Article

THE TIME COURSE OF TOLMETIN AND ITS METABOLITES IN THE PLASMA OF INDIVIDUAL RATS AND MICE.MIGDALOF BH; YORGEY KA; POPKAVE CG et al.1976; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1976; VOL. 4; NO 5; PP. 468-473; BIBL. 18 REF.Article

EFFECT OF FOOD ON THE BIOAVAILABILITY OF CAPTOPRIL IN HEALTHY SUBJECTSSINGHVI SM; MCKINSTRY DN; SHAW JM et al.1982; J. CLIN. PHARMACOL.; ISSN 0091-2700; USA; DA. 1982; VOL. 22; NO 2-3; PP. 135-140; BIBL. 8 REF.Article

PENFLURIDOL: A NEUROLEPTIC DRUG DESIGNED FOR LONG DURATION OF ACTIONMIGDALOF BH; GRINDEL JM; HEYKANTS JJP et al.1979; DRUG METABOL. REV.; USA; DA. 1979; VOL. 9; NO 2; PP. 281-299; BIBL. 22 REF.Article

RENAL HANDLING OF CAPTOPRIL: EFFECT OF PROBENECIDSINGHVI SM; DUCHIN KL; WILLARD DA et al.1982; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 2; PP. 182-189; BIBL. 13 REF.Article

BIOTRANSFORMATION OF MAZINDOL. I. ISOLATION AND IDENTIFICATION OF SOME METABOLITES FROM RAT URINEDUGGER HA; COOMBS RA; SCHWARZ HJ et al.1976; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1976; VOL. 4; NO 3; PP. 262-268; BIBL. 20 REF.Article

RENAL HANDLING OF ZOMEPIRAC SODIUM (MCN-2783-2138)O'NEILL PJ; YORGEY KA; MIGDALOF BH et al.1979; J. PHARMACOL. EXPER. THERAPEUT.; USA; DA. 1979; VOL. 209; NO 3; PP. 366-370; BIBL. 14 REF.Article

DISPOSITION OF CAPTOPRIL IN NORMAL SUBJECTSKRIPALANI KJ; MCKINSTRY DN; SINGHVI SM et al.1980; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1980; VOL. 27; NO 5; PP. 636-641; BIBL. 10 REF.Article

PHARMACOKINETICS OF CAPTOPRIL IN DOGS AND MONKEYSSINGHVI SM; PETERSON AE; ROSS JJR et al.1981; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1981; VOL. 70; NO 10; PP. 1108-1112; BIBL. 10 REF.Article

ABSORPTION AND BIOAVAILABILITY OF CAPTOPRIL IN MICE AND RATS AFTER ADMINISTRATION BY GAVAGE AND IN THE DIETSINGHVI SM; KRIPALANI KJ; DEAN AV et al.1981; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1981; VOL. 70; NO 8; PP. 885-888; BIBL. 10 REF.Article

ABSORPTION, DISTRIBUTION, AND EXCRETION OF FLUPROQUAZONE IN SEVERAL ANIMAL SPECIESWILLIAMS JI; BHUTA SI; JAFFE JM et al.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 5A; PP. 897-904; ABS. GER; BIBL. 3 REF.Article